2023 Testimonials

“Overall a fantastic conference. I learned so much about the degrader field and would recommend it to anyone.”

Senior Scientist, Deciphera Pharmaceuticals Inc.

“This event was a great opportunity to meet with colleagues and meet new people. The different tracks allow a rich exchange and a learning experience. This was a very useful and interesting event. Will definitely come back next year!”

Product Manager, NanoTemper Technologies Inc.

“This year's event had a terrific energy—full of innovation and thought provoking discussions. Fabulous to have the opportunity to meet up in-person with so many contacts and make new connections too!”

PhD, Independent Consultant

“Focused topics helped foster open and honest discussion on scientific challenges faced by delegates. The interactive sessions…helped me build my network and potential collaborations.”

PhD, Scientific Leader and GSK Fellow, Protein Cell and Structural Sciences, GlaxoSmithKline

“The breadth of coverage and disclosure of new advances in important fields like targeted protein degradation is impressive.”

PhD, Associate Director, Global Discovery Chemistry, Novartis Institutes for BioMedical Research

“Great conference—extremely well organized. Nice range of talks and great speakers.”

PhD, Head, Drug Discovery, Pin Therapeutics

“Excellent conference. Very well organized! Great for networking.”

PhD, Founder & President, NstructuredesignS, LLC

“Incredible meeting with incredible science!”

PhD, Senior Scientist, Biologics Engineering and Oncology R&D, AstraZeneca

“Great meeting, lots of interesting and diverse science. Useful networking as well.”

PhD, Research Fellow, Biology, Vernalis R&D Ltd.

“I felt the conference from an organizational perspective was fantastic. The location was easily accessible from the airport and the online portals made it very easy to know what talks were happening when and where. The breakout discussion was also very encouraging for me and I hope you continue to have sessions like this to draw newcomers into the field.”

Director, iBio Inc.

“I really enjoyed the conference, and it was great to listen to the excellent talks in multiple sessions. I will be viewing talks I missed using the on-demand feature which is very useful. I felt that the talks were very relevant to industry, and I enjoyed interacting with the speakers, as well as listening in on the group discussions which is a brilliant idea.”

Director, Aurigene

“I wanted to take the time to tell you how much I enjoyed this conference. You were able to successfully cover all aspects of drug/target discovery. It's been a real pleasure to participate in this effort.”

MD, Scientist Emeritus, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research

“It was a great meeting. I was able to make connections with an interdisciplinary array of scientists.”

Scientist, Dana-Farber Cancer Institute

“It was a great conference. The academia/pharma balance was good. Some of the pharma talks were very good despite them not disclosing everything. I have made important contacts and likely will have a couple of collaborations with both academia and industry.”

Associate Professor, New York University School of Medicine

“I enjoyed attending the conference. It was great to hear talks from prominent scientists in the field of targeted protein degradation. The event was well planned and organized.”

Associate Director, C4 Therapeutics